Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

NCT01270282 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinnitus

Interventions

DRUG: AM-101 0.81 mg/mL
DRUG: Placebo

Sponsor

Auris Medical, Inc.